Intrinsiqs

Is Chemed Corporation overvalued?

Chemed Corporation (CHE) looks overvalued — trading about 28% above its fair value.

Overvalued
Current price $512.16 Fair value $366.90
Price
$512.16
Fair value
$366.90
Current P/E
23.7
Normal P/E
17.0
Market cap
$6.69B
Dividend yield
0.5%
Return on equity
29.5%
Sector
Healthcare

See the full interactive analysis →

Fair value compares CHE's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 24 Sep 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.MRK Merck & Co., Inc.RHHBY Roche Holding AGUNH UnitedHealth Group Incorporated